BNP Paribas Financial Markets’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27K Hold
192,505
﹤0.01% 4988
2025
Q4
$53.9K Hold
192,505
﹤0.01% 4651
2025
Q3
$55.8K Buy
+192,505
New +$52.1K ﹤0.01% 4554

Other funds holding TDACW

BNP Paribas Financial Markets's TDACW Position: Q1 2026 in Review

BNP Paribas Financial Markets held its Translational Development Acquisition Corp Warrants (TDACW) position steady in Q1 2026 at 192,505 shares worth $27K. The position accounts for ﹤0.01% of the portfolio, ranked #4988.

BNP Paribas Financial Markets first reported a position in TDACW in Q3 2025 and has held it in 3 quarters since. The position peaked at $55.8K in Q3 2025. 32 funds tracked by Wall St. Rank hold TDACW as of Q1 2026.

  • BNP Paribas Financial Markets held 192,505 shares of Translational Development Acquisition Corp Warrants worth $27K as of Q1 2026.
  • BNP Paribas Financial Markets left its Translational Development Acquisition Corp Warrants share count unchanged in Q1 2026.
  • Translational Development Acquisition Corp Warrants made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #4988 holding.
  • BNP Paribas Financial Markets first reported a position in Translational Development Acquisition Corp Warrants in Q3 2025 and has held it in 3 quarters since.
  • BNP Paribas Financial Markets's Translational Development Acquisition Corp Warrants position peaked at $55.8K in Q3 2025.
  • 32 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.